Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Top Links You Must Click On


First in Michigan: Stem Cells to Preserve Heart Function

DETROIT, Jan. 7, 2013 /PRNewswire/ -- Physicians at Henry Ford Hospital are the first in Michigan in a new national research study to investigate treating a recent heart attack with a patient's own stem cells to preserve heart muscle function.

(Photo:  http://photos.prnewswire.com/prnh/20130107/DE37975 )

"Stem cell therapy offers new potential approaches in the treatment of acute heart attack patients to prevent further damage to heart muscle and improve function," says Gerald Koenig, M.D., Ph.D., a cardiologist and researcher at Henry Ford.  "Current standard treatment options only limit the weakening of the heart. This is why we are studying stem cell therapy, which looks very promising, but it is still an investigation, not an established treatment."

The body has a mechanism to repair itself. When a heart attack occurs, the heart sends a distress signal to the body, which then sends repair cells to the injury site. In some cases, depending on the severity of damage, the repair is insufficient, with a poor prognosis for the patient. A dead zone of tissue develops in the heart, while the surrounding healthy heart cells are stressed as they work harder to pump blood.

The American Heart Association, with the assistance of the National Institutes of Health, reports that an average of 16 years of life may be lost due to a heart attack.

"Previous studies using adult stem cells to limit heart muscle damage and improve function have had mixed success," says Dr. Koenig.  "Some studies have tried to do this too soon after a heart attack, and some tried the procedure at a later time. 

"It has been determined that there's a window of opportunity one week to 10 days after a heart attack which is the optimum time for stem cell treatment."

The type of stem cell used to treat heart muscle is critical for success, according to Dr. Koenig, as well as the number of cells infused.  When the correct amount of the right cells are used in the specified timeframe, the possibility of preserving heart function is much higher.

"We look for a specific stem cell that has the capability to improve the function of the heart, potentially by regenerating tissue, or as in this case, preventing the loss of heart muscle that typically continues for weeks after the heart attack," he says.

"An acute heart attack can severely weaken heart muscle.  Today's therapies, including balloon angioplasty and stents to reopen blocked blood vessels, and medication, have raised the survival rate for patients.  However, one third of heart attack survivors has a significant amount of damage to the heart, and is at high risk to develop congestive heart failure over several years."

Retired science teacher and former principal of Cass Tech High School, Lenora Ashford, 64, of Detroit, had a heart attack in mid November.  

It was determined that Ashford was qualified to participate in the investigational study, which has very strict entry criteria for patients.  She had marrow harvested from her hip bone to isolate her own stem cells for the procedure.  Two days later, pursuant to the study protocol, either placebo or the processed stem cells were infused through a catheter in the coronary artery to the area of damaged heart muscle. Both the harvesting and the infusion of stem cells are outpatient procedures.

"As a teacher, I always encouraged my students to participate in science projects," says Ashford.  "Now I could become part of a science project.  It was an opportunity to practice what I preached, and I felt it would be beneficial."

"You don't make progress unless you take chances," she adds.  "I have a lot of family members in the medical field and I discussed it with them.  They were very supportive, and I thought, why not?  Now, I feel so much better. Would I do it again?  Absolutely."

Henry Ford is participating in the PreSERVE AMI Phase II research study, which includes multiple hospitals in the U.S. The study is for adults who have received a stent to open a blocked artery after an acute heart attack, who also meet other entry criteria.

The PreSERVE study is sponsored by Amorcyte, LLC, a subsidiary of NeoStem, Inc.

SOURCE Henry Ford Hospital

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Enterprise Open Source Magazine Latest Stories . . .
DevOps is a discontinuous innovation in the way organizations develop and deliver software. And as with any new discontinuous innovation, the implication is that creative destruction will follow. Companies that hold on to legacy business and technology models, without pursuing the ev...
What are the benefits of using an enterprise-grade orchestration platform? In their session at 15th Cloud Expo, Jeff Tegethoff, CEO of Appcore, and Kedar Poduri, Senior Director of Product Management at Citrix Systems, will take a closer look at the architectural design factors neede...
StackIQ offers a comprehensive software suite that automates the deployment, provisioning, and management of Big Infrastructure. With StackIQ’s software, you can spin up fully configured big data clusters, quickly and consistently — from bare-metal up to the applications layer — and ma...
Here’s the presentation I gave at the Linux Foundation’s CloudOpen in Dusseldorf on October 13, 2014 titled Mixing Your Open Source Cloud Cocktail Add two parts virtualization, one part orchestration add a little networking shake and pour. Unfortunately cloud computing isn’...
There's fog coming to the world of IT. Some people are calling this "The Cloud." This fog turns everything inside out. It will take your monolithic applications, the guts of which are contained within large bodies of code, and break them apart so that discrete units of functionality a...
In his session at 15th Cloud Expo, Mark Hinkle, Senior Director, Open Source Solutions at Citrix Systems Inc., will provide overview of the open source software that can be used to deploy and manage a cloud computing environment. He will include information on storage, networking(e.g.,...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE